These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High expression of methionine aminopeptidase 2 in human colorectal adenocarcinomas. Selvakumar P; Lakshmikuttyamma A; Kanthan R; Kanthan SC; Dimmock JR; Sharma RK Clin Cancer Res; 2004 Apr; 10(8):2771-5. PubMed ID: 15102683 [TBL] [Abstract][Full Text] [Related]
3. Expression of methionine aminopeptidase 2, N-myristoyltransferase, and N-myristoyltransferase inhibitor protein 71 in HT29. Selvakumar P; Lakshmikuttyamma A; Lawman Z; Bonham K; Dimmock JR; Sharma RK Biochem Biophys Res Commun; 2004 Sep; 322(3):1012-7. PubMed ID: 15336565 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases. Wang J; Lou P; Henkin J J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954 [TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784 [TBL] [Abstract][Full Text] [Related]
6. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943 [TBL] [Abstract][Full Text] [Related]
7. Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression. Hu X; Addlagatta A; Lu J; Matthews BW; Liu JO Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18148-53. PubMed ID: 17114291 [TBL] [Abstract][Full Text] [Related]
8. High expression of methionine aminopeptidase type 2 in germinal center B cells and their neoplastic counterparts. Kanno T; Endo H; Takeuchi K; Morishita Y; Fukayama M; Mori S Lab Invest; 2002 Jul; 82(7):893-901. PubMed ID: 12118091 [TBL] [Abstract][Full Text] [Related]
9. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570 [TBL] [Abstract][Full Text] [Related]
10. MetAP1 and MetAP2 drive cell selectivity for a potent anti-cancer agent in synergy, by controlling glutathione redox state. Frottin F; Bienvenut WV; Bignon J; Jacquet E; Vaca Jacome AS; Van Dorsselaer A; Cianferani S; Carapito C; Meinnel T; Giglione C Oncotarget; 2016 Sep; 7(39):63306-63323. PubMed ID: 27542228 [TBL] [Abstract][Full Text] [Related]
11. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target. Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475 [TBL] [Abstract][Full Text] [Related]
12. NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells. Selvakumar P; Lakshmikuttyamma A; Das U; Pati HN; Dimmock JR; Sharma RK Mol Cancer; 2009 Aug; 8():65. PubMed ID: 19703310 [TBL] [Abstract][Full Text] [Related]
14. Methionine aminopeptidase 2 is required for HSC initiation and proliferation. Ma AC; Fung TK; Lin RH; Chung MI; Yang D; Ekker SC; Leung AY Blood; 2011 Nov; 118(20):5448-57. PubMed ID: 21937698 [TBL] [Abstract][Full Text] [Related]
15. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4. Endo H; Takenaga K; Kanno T; Satoh H; Mori S J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292 [TBL] [Abstract][Full Text] [Related]
16. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity. Catalano A; Romano M; Robuffo I; Strizzi L; Procopio A Am J Pathol; 2001 Aug; 159(2):721-31. PubMed ID: 11485930 [TBL] [Abstract][Full Text] [Related]
17. Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models. Friese-Hamim M; Ortiz Ruiz MJ; Bogatyrova O; Keil M; Rohdich F; Blume B; Leuthner B; Czauderna F; Hahn D; Jabs J; Jaehrling F; Heinrich T; Kellner R; Chan K; Tong AHY; Wienke D; Moffat J; Blaukat A; Zenke FT Mol Cancer Ther; 2024 Feb; 23(2):159-173. PubMed ID: 37940144 [TBL] [Abstract][Full Text] [Related]
18. Omics Assisted N-terminal Proteoform and Protein Expression Profiling On Methionine Aminopeptidase 1 (MetAP1) Deletion. Jonckheere V; Fijałkowska D; Van Damme P Mol Cell Proteomics; 2018 Apr; 17(4):694-708. PubMed ID: 29317475 [TBL] [Abstract][Full Text] [Related]
19. Identification of potential inhibitors of human methionine aminopeptidase (type II) for cancer therapy: Structure-based virtual screening, ADMET prediction and molecular dynamics studies. Weako J; Uba AI; Keskin Ö; Gürsoy A; Yelekçi K Comput Biol Chem; 2020 Jun; 86():107244. PubMed ID: 32252002 [TBL] [Abstract][Full Text] [Related]